Shifang Yang
- Topics
- Cell death mechanisms and regulation (12 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers)Antibiotic Use and Resistance (4 papers)
In The Last Decade
Shifang Yang
30 papers receiving 440 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 202
- Immunology 88
- Pulmonary and Respiratory Medicine 84
- Infectious Diseases 84
- Oncology 60
Countries citing papers authored by Shifang Yang
This map shows the geographic impact of Shifang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifang Yang more than expected).
Fields of papers citing papers by Shifang Yang
This network shows the impact of papers produced by Shifang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifang Yang. The network helps show where Shifang Yang may publish in the future.
Co-authorship network of co-authors of Shifang Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Shifang Yang. A scholar is included among the top collaborators of Shifang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifang Yang. Shifang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 25 | |
| 6 | 11 | |
| 7 | 4 | |
| 8 | 11 | |
| 9 | 5 | |
| 10 | 17 | |
| 11 | 1 | |
| 12 | 97 | |
| 13 | 9 | |
| 14 | 19 | |
| 15 | 49 | |
| 16 | 7 | |
| 17 | 13 | |
| 18 | 5 | |
| 19 | 25 | |
| 20 | [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo]. | 2 |
About Shifang Yang
Shifang Yang is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Cancer Research, having authored 34 papers that have together received 451 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (22 citations), Modeling and Simulation (33 citations) and Infectious Diseases (84 citations). Shifang Yang has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Jungang Xie, Xinglin Gao, Jianping Zhao, Yongjian Xu, Yiyu Deng, Hanyi Xu, Zixing Chen, Xuefu Chen, Ming Gao and Aiping Wang. Their work appears in journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.